Prostate Cancer - Results from #28660

Prostate cancer in Spain: From guidelines to clinical practice - Abstract February 15, 2011

Is a decreased serum testosterone level a risk factor for prostate cancer? A cohort study of Korean men - Abstract February 15, 2011

Editor's Commentary - Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer February 15, 2011

The genomic complexity of primary human prostate cancer - Abstract February 15, 2011

Research presented at 2011 Genitourinary Cancers Symposium highlights advances in management, treatment of prostate cancer February 15, 2011

Changing therapeutic paradigms in castrate-resistant prostate cancer - Abstract February 14, 2011

Rectourethral fistula after high-intensity focused ultrasound therapy for prostate cancer and its surgical management - Abstract February 14, 2011

Factors that influence patient enrollment in active surveillance for low-risk prostate cancer - Abstract February 14, 2011

Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer - Abstract February 14, 2011

ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program - Abstract February 14, 2011

Initial biopsy outcome prediction in Korean patients-comparison of a noble web-based Korean prostate cancer risk calculator versus prostate-specific antigen testing - Abstract February 14, 2011

The health and well-being of prostate cancer patients and male-to-female transsexuals on androgen deprivation therapy: A qualitative study with comments on expectations and estrogen - Abstract February 14, 2011

Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer - Abstract February 11, 2011

How to improve the surgery of prostate cancer? - Abstract February 11, 2011

Intimacy-enhancing psychological intervention for men diagnosed with prostate cancer and their partners: A pilot study - Abstract February 11, 2011

Contemporary therapeutic approaches targeting bone complications in prostate cancer - Abstract February 11, 2011

Improving outcomes with recent advances in chemotherapy for castrate-resistant prostate cancer - Abstract February 11, 2011

The current and emerging role of immunotherapy in prostate cancer - Abstract February 11, 2011

Prediction of pathological outcomes for a single microfocal (≤ 3 mm) Gleason 6 prostate cancer detected via contemporary multicore (≥12) biopsy in men with prostate-specific antigen ≤ 10 ng/mL - Abstract February 11, 2011

iProstate, a mathematical predictive model-based, 3D-rendering tool to visualize the location and extent of prostate cancer - Abstract February 10, 2011

Page 1434 of 1438